ロード中...
A Public Health Approach to the Prevention of Inhibitors in Hemophilia
The development of an antibody in people with hemophilia to products used in the treatment and prevention of bleeding, also referred to as an inhibitor, is the most serious complication of hemophilia care today. CDC, together with healthcare providers, consumer organizations, hemophilia organization...
保存先:
| 出版年: | Am J Prev Med |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4469363/ https://ncbi.nlm.nih.gov/pubmed/25245801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amepre.2014.07.007 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|